共 481 条
- [1] Humbert M(2019)Pathology and pathobiology of pulmonary hypertension: state of the art and research perspectives Eur Respir J 53 1801887-1391
- [2] Guignabert C(2022)Diagnosis and treatment of pulmonary arterial hypertension: a review JAMA 327 1379-1896
- [3] Bonnet S(2019)Inflammasomes: a novel therapeutic target in pulmonary hypertension? Br J Pharmacol 176 1880-2782
- [4] Dorfmüller P(2021)Pyroptosis: mechanisms and diseases Signal Transduct Target Ther 6 128-597
- [5] Klinger JR(2021)Gasdermin D in pyroptosis Acta Pharmaceutica Sinica B 11 2768-665
- [6] Nicolls MR(2015)Regulation of inflammasome activation Immunol Rev 265 6-33
- [7] Olschewski AJ(2015)Nedd8 regulates inflammasome-dependent caspase-1 activation Mol Cell Biol 35 582-L482
- [8] Pullamsetti SS(2015)Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death Nature 526 660-934
- [9] Schermuly RT(2020)Programmed death-ligand 1 triggers PASMCs pyroptosis and pulmonary vascular fibrosis in pulmonary hypertension J Mol Cell Cardiol 138 23-5711
- [10] Stenmark KR(2020)GLI1-mediated pulmonary artery smooth muscle cell pyroptosis contributes to hypoxia-induced pulmonary hypertension Am J Physiol Lung Cell Mol Physiol 318 L472-L387